Effect of intra-knee injection of autologous adipose stem cells or mesenchymal vascular components on short-term outcomes in patients with knee osteoarthritis: an updated meta-analysis of randomized controlled trials
- PMID: 37563715
- PMCID: PMC10413774
- DOI: 10.1186/s13075-023-03134-3
Effect of intra-knee injection of autologous adipose stem cells or mesenchymal vascular components on short-term outcomes in patients with knee osteoarthritis: an updated meta-analysis of randomized controlled trials
Abstract
Objective: Assess the efficacy of single and multiple intra-articular injections of autologous adipose-derived stem cells (ASCs) and adipose-derived stromal vascular fraction (ADSVF) for the treatment of knee osteoarthritis (OA).
Methods: We conducted a thorough and systematic search of several databases, including PubMed, Embase, Web of Science, Cochrane Library, and ClinicalTrials.gov, to identify relevant studies. The included studies were randomized controlled trials (RCTs) that involved single or multiple intra-articular injections of autologous ASCs or ADSVF for the treatment of patients with knee osteoarthritis, without any additional treatment, and compared to either placebo or hyaluronic acid.
Results: A total of seven RCTs were analyzed in this study. The results of the meta-analysis show that compared to the control group, both single and multiple intra-articular injections of ASCs or ADSVF demonstrated superior pain relief in the short term (Z = 3.10; P < 0.0001 and Z = 4.66; P < 0.00001) and significantly improved function (Z = 2.61; P < 0.009 and Z = 2.80; P = 0.005). Furthermore, MRI assessment showed a significant improvement in cartilage condition compared to the control group. (Z = 8.14; P < 0.000001 and Z = 5.58; P < 0.00001).
Conclusions: In conclusion, in osteoarthritis of the knee, single or multiple intra-articular injections of autologous ASCs or ADSVF have shown significant pain improvement and safety in the short term in the absence of adjuvant therapy. Significant improvements in cartilage status were also shown. A larger sample size of randomized controlled trials is needed for direct comparison of the difference in effect between single and multiple injections.
Keywords: Adipose-derived stem cells; Knee osteoarthritis; Stromal vascular fraction.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials.Am J Sports Med. 2023 Mar;51(3):837-848. doi: 10.1177/03635465211053893. Epub 2022 Jan 12. Am J Sports Med. 2023. PMID: 35019764
-
Autologous adipose stem cell therapy for knee osteoarthritis: where are we now?Phys Sportsmed. 2020 Nov;48(4):392-399. doi: 10.1080/00913847.2020.1758001. Epub 2020 Apr 27. Phys Sportsmed. 2020. PMID: 32312142
-
Intra-Articular Mesenchymal Stromal Cell Injections Are No Different From Placebo in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials.Arthroscopy. 2021 Jan;37(1):340-358. doi: 10.1016/j.arthro.2020.10.016. Epub 2020 Oct 21. Arthroscopy. 2021. PMID: 33098949
-
Intra-articular injection of mesenchymal stem cells for clinical outcomes and cartilage repair in osteoarthritis of the knee: a meta-analysis of randomized controlled trials.Arch Orthop Trauma Surg. 2019 Jul;139(7):971-980. doi: 10.1007/s00402-019-03140-8. Epub 2019 Feb 11. Arch Orthop Trauma Surg. 2019. PMID: 30756165 Review.
-
The efficacy of intra-articular injections in the treatment of knee osteoarthritis: A network meta-analysis of randomized controlled trials.Knee. 2021 Oct;32:173-182. doi: 10.1016/j.knee.2021.08.008. Epub 2021 Sep 6. Knee. 2021. PMID: 34500430 Review.
Cited by
-
Recent Trends in Adipose Tissue-Derived Injectable Therapies for Osteoarthritis: A Scoping Review of Animal Models.Medicina (Kaunas). 2024 Apr 25;60(5):707. doi: 10.3390/medicina60050707. Medicina (Kaunas). 2024. PMID: 38792890 Free PMC article. Review.
-
Comparative single-cell transcriptional and proteomic atlas of clinical-grade injectable mesenchymal source tissues.Sci Adv. 2024 Jul 12;10(28):eadn2831. doi: 10.1126/sciadv.adn2831. Epub 2024 Jul 12. Sci Adv. 2024. PMID: 38996032 Free PMC article.
-
Intra-Articular Application of Autologous, Fat-Derived Orthobiologics in the Treatment of Knee Osteoarthritis: A Systematic Review.Cells. 2024 Apr 25;13(9):750. doi: 10.3390/cells13090750. Cells. 2024. PMID: 38727286 Free PMC article.
-
Stromal Vascular Fraction Therapy for Knee Osteoarthritis: A Systematic Review.Medicina (Kaunas). 2023 Nov 28;59(12):2090. doi: 10.3390/medicina59122090. Medicina (Kaunas). 2023. PMID: 38138193 Free PMC article. Review.
-
Intra-Articular Injection of Adipose-Derived Stromal Vascular Fraction in Osteoarthritic Temporomandibular Joints: Study Design of a Randomized Controlled Clinical Trial.Bioengineering (Basel). 2024 Feb 10;11(2):171. doi: 10.3390/bioengineering11020171. Bioengineering (Basel). 2024. PMID: 38391657 Free PMC article.
References
-
- Callahan LF, Ambrose KR, Albright AL, Altpeter M, Golightly YM, Huffman KF, et al. Public Health Interventions for Osteoarthritis - updates on the Osteoarthritis Action Alliance's efforts to address the 2010 OA Public Health Agenda Recommendations. Clin Exp Rheumatol. 2019;5:31–39. - PubMed
-
- Hawker GA. Osteoarthritis is a serious disease. Clin Exp Rheumatol. 2019;5:3–6. - PubMed
-
- Brown GA. AAOS clinical practice guideline: treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Sur. 2013;9(559): 557. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources